The Role of JNK in Insulin Sensitivity and Obesity
Author Information
Author(s): Vallerie Sara N. Furuhashi, Masato Fucho, Raquel Hotamisligil, Gökhan S. Hotamisligil
Primary Institution: Harvard School of Public Health
Hypothesis
Does the activity of c-Jun N-terminal kinase (JNK) in macrophages contribute to insulin sensitivity and obesity-related inflammation?
Conclusion
The study found that JNK1 activity in parenchymal tissues is crucial for regulating systemic insulin sensitivity, while its activity in bone marrow-derived cells has a lesser impact.
Supporting Evidence
- JNK1-deficiency in bone marrow-derived elements did not significantly impact insulin sensitivity.
- Only parenchymal JNK1 deficiency led to a notable increase in systemic insulin sensitivity.
- Inflammatory cytokine levels were lower in JNK1-deficient mice compared to controls.
Takeaway
This study shows that a specific protein called JNK1 in certain cells helps control how well our body uses insulin, which is important for managing weight and diabetes.
Methodology
The researchers used bone marrow transplantation in mice to study the effects of JNK1 deficiency on insulin sensitivity and inflammation.
Limitations
The study did not observe changes in body weight between chimeric groups, which may affect the interpretation of insulin sensitivity results.
Participant Demographics
C57BL/6 male mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website